PAHO Partners With US Hospital to Improve Access to Childhood Cancer Medication in the Americas

WASHINGTON, DC – The Pan American Health Organization (PAHO) says it has entered into a new partnership agreement with the US-based St. Jude Children’s Research Hospital to help strengthen equitable access to childhood cancer medications for children in Latin America and the Caribbean (LAC).

Smile, nurse and child on bed in hospital for children, health and medicine, support and trust in cancer treatment. Paediatrics, healthcare and kid, nursing caregiver holding hands with young patientThe four-year agreement will focus on the supply of guaranteed quality medicines through the PAHO Strategic Fund, in order to support the organization’s technical cooperation with member states to strengthen health care services. childhood cancer and drug management systems.

PAHO said its goal is to improve outcomes from childhood cancer, which affects more than 47,000 children and claims more than 12,000 lives each year in the region.

“In the Americas, childhood cancer survival rates vary between countries, highlighting disparities,” said Dr. Jarbas Barbosa, Director of PAHO.

He said this is due to differences in the quality of care services. and treatment, including access to timely diagnosis and adherence to treatment.

Under the new agreement, the PAHO Strategic Fund will work on the implementation of the Global Platform for Access to Medicines against Childhood Cancer in Latin America and the Caribbean. This global initiative will provide a supply of quality-assured childhood cancer medicines to low- and middle-income countries.

PAHO said the platform will provide comprehensive support for drug supply, assist countries in drug selection, develop treatment standards, and create information systems to drive evidence-based innovation.

It said an estimated 120,000 children around the world are expected to benefit in this first phase until 2027.

“The Global Platform for Access to Medicines for Childhood Cancer is an innovative and transformative initiative. It will create a coordinated approach for the purchase and distribution of essential medicines for children with cancer, easing the financial burden on governments, hospitals and families,” said Carlos Rodríguez-Galindo, Director of St. Jude Global.

The alliance supports PAHO’s broader commitment to address complex health challenges, ensure equitable access to essential medicines, and build a healthier future for all children in the Americas.

Meanwhile,PAHO said that it is estimated that at least 30,000 girls, boys and adolescents under 19 years of age in LAC will be affected by cancer annually and that about 10,000 will die from this disease.

PAHO made the disclosure in a message marking International Childhood Cancer Day on Thursday.